BioSpace News Archive

Deals

Theralase® Grants Stock Options

Theralase® Technologies Inc. announces the grant of stock options.

November 21, 2022
·
3 min read
Biotech Bay

ASLAN Pharmaceuticals to Participate in a Fireside Chat at 34th Annual Piper Sandler Healthcare Conference

ASLAN Pharmaceuticals today announced Dr Carl Firth, CEO, is scheduled to participate in a fireside chat at the Piper Sandler Healthcare Conference on Thursday, December 1, 2022, at 8:30am ET.

November 21, 2022
·
1 min read
FDA

Zimmer Biomet Expands Persona® Knee System Portfolio with FDA Clearance of Persona® OsseoTi® Keel Tibia for Cementless Knee Replacement

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Persona® OsseoTi® Keel Tibia for cementless knee replacement.

November 21, 2022
·
5 min read
Genetown

Leap Therapeutics to Participate at the Piper Sandler 34th Annual Healthcare Conference

Leap Therapeutics, Inc. today announced that Douglas E. Onsi , President and Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference, being held in New York.

November 21, 2022
·
3 min read
Genetown

Syndax Announces Participation at Evercore ISI Annual HealthCONx Conference

Syndax Pharmaceuticals, Inc. today announced that members of its management team will participate in a fireside chat at the Evercore ISI Annual HealthCONx Conference on Wednesday, November 30, 2022, at 3:30 p.m.

November 21, 2022
·
1 min read
Genetown

PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays

PerkinElmer, Inc. , (NYSE:PKI), a global leader committed to innovating for a healthier world, today launched ready-to-use Adeno-associated Virus Vectors (AAV) Detection Kits to support researchers working on gene therapies for a variety of serious diseases.

November 21, 2022
·
3 min read